Adenosine and ATP differentially control osteogenic gene expression patterns in a cardiac valve cell line
Cardiology Journal · 2026
DOI: 10.5603/cj.105530 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cardiology Journal, 2026. Verfasst von Tomasz Borkowski und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Laboratory Diagnostics - Fahrenheit Biobank BBMRI.pl, Medical University of Gdansk, Gdansk, Poland. tomasz.borkowski@gumed.edu.…. Hauptthemen laut MEDLINE: Adenosine Triphosphate, Adenosine, Osteogenesis, Aortic Valve. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Introduction
Calcific aortic valve disease (CAVD) involves the osteogenic transition of valve interstitial cells (VICs) and is influenced by purinergic signaling. ATP is considered pro-calcific, whereas adenosine (Ado) has been reported as anti- or pro-calcific. Extracellular conversion of ATP to Ado by ecto-enzymes (including ecto-5’-nucleotidase, CD73) may shape receptor signaling in VICs. Material and methods. We quantified osteogenic and apoptotic markers in the murine valve-like cell line tsA58-AVM under osteogenic conditions after treatment with ATP or Ado, selective Adora1/Adora2A agonists, and/or CD73.
Results
Runt-related transcription factor 2, isoform II (Runx2-II) expression decreased by 31% and 17% after 16 hours of exposure to 0.35 μM and 3.5 μM Ado, respectively. Adora1 activation (MeCCPA, 0.1 μM) reduced Runx2-II by 49–57% on days 1–5, and Adora2A activation (PSB0777, 1 μM) reduced Runx2-II by 17–63% at days 1–5. Repeated ATP addition (100 μM) increased osteopontin (SPP1) by 7.7- and 3.3-fold and osteocalcin (BGLAP) by 14.4- and 4.0-fold on days 5 and 12, respectively; cotreatment with CD73 (0.1 ng/μL) reduced or normalized these changes. ATP also doubled the Bcl-2- associated X protein (Bax) to B-cell lymphoma 2 protein (BCL2) ratio, an effect that was prevented by CD73.
Conclusions
Purinergic ligands and receptors directly regulate VIC osteogenic differentiation and apoptosis in vitro without exogenous inflammatory stimulation. Modulation of the ATP-Ado axis may represent a therapeutic target to slow CAVD progression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Laboratory Diagnostics - Fahrenheit Biobank BBMRI.pl, Medical University of Gdansk, Gdansk, Poland. tomasz.borkowski@gumed.edu.pl.
- Department of Cellular and Molecular Medicine, University of Arizona College of Medicine, Tucson, Arizona, United States. tomasz.borkowski@gumed.edu.pl.
- Department of Medical Laboratory Diagnostics - Fahrenheit Biobank BBMRI.pl, Medical University of Gdansk, Gdansk, Poland.
- Department of Biochemistry, Medical University of Gdansk, Gdansk, Poland.
- Department of Cardiothoracic Surgery, Heart and Vascular Institute, Honor Health, Scottsdale, Arizona, United States.
- Department of Cellular and Molecular Medicine, University of Arizona College of Medicine, Tucson, Arizona, United States.
ORCID-Profile: Tomasz Borkowski, Agata Płoska, Ryszard T Smoleński, Zain Khalpey, Raymond B Runyan, Rafał Bartoszewski, Miłosz Jaguszewski, Leszek Kalinowski
Zitieren
APA
Borkowski, T., Płoska, A., Smoleński, R. T., Khalpey, Z., Runyan, R. B., Bartoszewski, R., Jaguszewski, M., & Kalinowski, L. (2026). Adenosine and ATP differentially control osteogenic gene expression patterns in a cardiac valve cell line. Cardiology Journal. https://doi.org/10.5603/cj.105530
Vancouver
Borkowski T, Płoska A, Smoleński RT, Khalpey Z, Runyan RB, Bartoszewski R, et al. Adenosine and ATP differentially control osteogenic gene expression patterns in a cardiac valve cell line. Cardiology Journal. 2026. doi:10.5603/cj.105530
BibTeX
@article{Borkowski2026,
author = {Borkowski, Tomasz and Płoska, Agata and Smoleński, Ryszard T and Khalpey, Zain and Runyan, Raymond B and Bartoszewski, Rafał and Jaguszewski, Miłosz and Kalinowski, Leszek},
title = {Adenosine and ATP differentially control osteogenic gene expression patterns in a cardiac valve cell line},
journal = {Cardiology Journal},
year = {2026},
doi = {10.5603/cj.105530}
}
EUVIMED